(Q44448472)

3 December 2017

Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme (English)

1 reference

3 December 2017

1 reference

1 reference

Jean Marc Simon

1

1 reference

3 December 2017

Georges Noël

2

1 reference

3 December 2017

Jacques Chiras

3

1 reference

3 December 2017

Khê Hoang-Xuan

4

1 reference

3 December 2017

Jean Yves Delattre

5

1 reference

3 December 2017

François Baillet

6

1 reference

3 December 2017

Jean Jacques Mazeron

7

1 reference

3 December 2017

1 April 2003

1 reference

Radiotherapy and Oncology

3 December 2017

1 reference

3 December 2017

67

1 reference

3 December 2017

1

1 reference

3 December 2017

45-51

1 reference

Carbogen inhalation in cervical cancer: assessment of oxygenation change

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Intratumoral oxygen pressure in malignant brain tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

A pilot study comparing intratumoral oxygenation using the comet assay following 2.5% and 5% carbogen and 100% oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Cerebral bloodflow in and around spontaneous malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900007-0

7 January 2021

10.1016/S0167-8140(03)00007-0

Identifiers

DOI

1 reference

3 December 2017

1 reference